These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33045355)

  • 1. Immunomodulatory effects of colistin on host responses against carbapenem-resistant Klebsiella pneumoniae biofilms.
    Geladari A; Simitsopoulou M; Antachopoulos C; Roilides E
    Int J Antimicrob Agents; 2020 Dec; 56(6):106182. PubMed ID: 33045355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms.
    Geladari A; Simitsopoulou M; Antachopoulos C; Roilides E
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin exerts differential immunomodulatory effects on host responses against methicillin-resistant Staphylococcus aureus biofilms.
    Simitsopoulou M; Kadiltzoglou P; Antachopoulos C; Roilides E
    Int J Antimicrob Agents; 2022 Oct; 60(4):106666. PubMed ID: 36038095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.
    Richter SS; Karichu J; Otiso J; Van Heule H; Keller G; Cober E; Rojas LJ; Hujer AM; Hujer KM; Marshall S; Perez F; Rudin SD; Domitrovic TN; Kaye KS; Salata R; van Duin D; Bonomo RA
    Diagn Microbiol Infect Dis; 2018 May; 91(1):89-92. PubMed ID: 29456071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients.
    Banerjee K; Motley MP; Diago-Navarro E; Fries BC
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33658281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.
    Hamel M; Chatzipanagiotou S; Hadjadj L; Petinaki E; Papagianni S; Charalampaki N; Tsiplakou S; Papaioannou V; Skarmoutsou N; Spiliopoulou I; Christofidou M; Papamichalopoulos N; Skalidis T; Legakis N; Fountoulis K; Perivolioti E; Kraniotaki H; Bournia M; Ioannidis A; Baron Sophie A; Rolain JM
    Int J Antimicrob Agents; 2020 Apr; 55(4):105930. PubMed ID: 32130981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of IgG Subclass in Antibody-Mediated Protection against Carbapenem-Resistant Klebsiella pneumoniae.
    Motley MP; Diago-Navarro E; Banerjee K; Inzerillo S; Fries BC
    mBio; 2020 Sep; 11(5):. PubMed ID: 32900809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis.
    Tansarli GS; Papaparaskevas J; Balaska M; Samarkos M; Pantazatou A; Markogiannakis A; Mantzourani M; Polonyfi K; Daikos GL
    Int J Antimicrob Agents; 2018 Sep; 52(3):397-403. PubMed ID: 29960007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aminoglycosides and colistin inhibit biofilm formation in Klebsiella pneumoniae].
    Hostacká A; Ciznár I
    Epidemiol Mikrobiol Imunol; 2008 Aug; 57(3):101-5. PubMed ID: 18767377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae.
    Cusumano JA; Caffrey AR; Daffinee KE; Luther MK; Lopes V; LaPlante KL
    Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114877. PubMed ID: 31484626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
    Ku YH; Chen CC; Lee MF; Chuang YC; Tang HJ; Yu WL
    J Microbiol Immunol Infect; 2017 Dec; 50(6):931-939. PubMed ID: 28716360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteroresistance to colistin in Klebsiella pneumoniae is triggered by small colony variants sub-populations within biofilms.
    Silva A; Sousa AM; Alves D; Lourenço A; Pereira MO
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27140200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates.
    Galani I; Adamou P; Karaiskos I; Giamarellou H; Souli M
    J Glob Antimicrob Resist; 2018 Dec; 15():123-126. PubMed ID: 30036693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between antimicrobial consumption and the prevalence of carbapenem-resistant Escherichia coli and carbapenem-resistant Klebsiella pneumoniae at a university hospital in Thailand.
    Prakobsrikul N; Malathum K; Santanirand P; Chumnumwat S; Piebpien P; Montakantikul P
    J Clin Pharm Ther; 2019 Apr; 44(2):292-299. PubMed ID: 30578578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and molecular characterisation of colistin-resistant Klebsiella pneumoniae isolates from immunocompromised patients in Tunisia.
    Tanfous FB; Raddaoui A; Chebbi Y; Achour W
    Int J Antimicrob Agents; 2018 Dec; 52(6):861-865. PubMed ID: 30176353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASK2 Bioactive Compound Inhibits MDR
    Lalitha C; Raman T; Rathore SS; Ramar M; Munusamy A; Ramakrishnan J
    Front Cell Infect Microbiol; 2017; 7():346. PubMed ID: 28824881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae.
    Crémieux AC; Dinh A; Nordmann P; Mouton W; Tattevin P; Ghout I; Jayol A; Aimer O; Gatin L; Verdier MC; Saleh-Mghir A; Laurent F
    J Antimicrob Chemother; 2019 Sep; 74(9):2666-2675. PubMed ID: 31263884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae.
    Jayol A; Nordmann P; Poirel L; Dubois V
    J Antimicrob Chemother; 2018 Feb; 73(2):542-544. PubMed ID: 29165563
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial activity of eugenol against carbapenem-resistant Klebsiella pneumoniae and its effect on biofilms.
    Qian W; Sun Z; Wang T; Yang M; Liu M; Zhang J; Li Y
    Microb Pathog; 2020 Feb; 139():103924. PubMed ID: 31837416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.